Asset Management One Co. Ltd. Boosts Stock Position in Avantor, Inc. (NYSE:AVTR)

Asset Management One Co. Ltd. boosted its position in Avantor, Inc. (NYSE:AVTR - Free Report) by 10.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 260,109 shares of the company's stock after purchasing an additional 23,639 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Avantor were worth $4,216,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Oppenheimer Asset Management Inc. raised its holdings in Avantor by 13.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 124,101 shares of the company's stock valued at $2,012,000 after acquiring an additional 14,761 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Avantor during the first quarter worth $320,000. Kentucky Retirement Systems purchased a new stake in shares of Avantor in the first quarter valued at $751,000. Castleview Partners LLC grew its position in shares of Avantor by 56.1% in the first quarter. Castleview Partners LLC now owns 27,537 shares of the company's stock valued at $446,000 after purchasing an additional 9,891 shares during the period. Finally, Norris Perne & French LLP MI increased its stake in Avantor by 91.1% in the first quarter. Norris Perne & French LLP MI now owns 956,625 shares of the company's stock valued at $15,507,000 after purchasing an additional 455,963 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Avantor

In related news, Director Gregory L. Summe purchased 25,000 shares of the firm's stock in a transaction on Wednesday, May 7th. The stock was purchased at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the acquisition, the director now directly owns 50,000 shares in the company, valued at $600,000. The trade was a 100.00% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Joseph R. Massaro acquired 8,100 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were purchased at an average price of $12.30 per share, for a total transaction of $99,630.00. Following the purchase, the director now directly owns 35,038 shares of the company's stock, valued at approximately $430,967.40. This trade represents a 30.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have purchased 83,100 shares of company stock valued at $1,027,630 over the last three months. 1.20% of the stock is owned by company insiders.

Avantor Trading Down 1.4%

Shares of AVTR stock opened at $13.55 on Monday. The company has a quick ratio of 0.75, a current ratio of 1.12 and a debt-to-equity ratio of 0.54. Avantor, Inc. has a fifty-two week low of $11.82 and a fifty-two week high of $28.00. The firm's 50 day moving average price is $13.23 and its two-hundred day moving average price is $16.82. The stock has a market cap of $9.23 billion, a price-to-earnings ratio of 13.03, a price-to-earnings-growth ratio of 1.44 and a beta of 1.04.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, meeting analysts' consensus estimates of $0.23. Avantor had a net margin of 10.70% and a return on equity of 11.93%. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.61 billion. During the same quarter last year, the firm posted $0.22 EPS. The business's revenue for the quarter was down 5.9% compared to the same quarter last year. On average, analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on AVTR shares. Barclays decreased their price target on Avantor from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Morgan Stanley lowered shares of Avantor from an "overweight" rating to an "equal weight" rating in a report on Tuesday, April 29th. Wells Fargo & Company decreased their target price on shares of Avantor from $25.00 to $22.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. TD Cowen lowered shares of Avantor from a "buy" rating to a "hold" rating and set a $15.50 price target for the company. in a research report on Monday, April 28th. Finally, Cowen downgraded shares of Avantor from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Seven investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $18.88.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.